{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:48:14Z","timestamp":1791413294475,"version":"4.3.3"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tumor-induced osteomalacia (TIO) is a rare and largely underdiagnosed paraneoplastic condition. Previous reviews often reported incomplete data on clinical aspects, diagnosis or prognosis. The aim of this study was to present a systematic clinical review of all published cases of TIO. A search was conducted in Pubmed, Embase, Web of Science from inception until April 23rd, 2020. We selected case reports and case series of patients diagnosed with TIO, with information on tumor localization and serum phosphate concentration. Two reviewers independently extracted data on biochemical and clinical characteristics including bone involvement, tumor localization and treatment. 468 articles with 895 unique TIO cases were included. Median age was 46\u00a0years (range 9 months\u201390\u00a0years) and 58.3% were males. Hypophosphatemia and inappropriately low or normal 1,25-dihydroxyvitamin D levels, characteristic for TIO, were present in 98% of cases. Median tumor size was 2.7\u00a0cm (range 0.5 to 25.0\u00a0cm). Serum fibroblast growth factor 23 was related to tumor size (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.344,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001). In 32% of the cases the tumor was detected by physical examination. Data on bone phenotype confirmed skeletal involvement: 62% of cases with BMD data had a T-score of the lumbar spine\u2009\u2264\u2009\u2212\u00a02.5 (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200961\/99) and a fracture was reported in at least 39% of all cases (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009346\/895). Diagnostic delay was longer than 2\u00a0years in more than 80% of cases. 10% were reported to be malignant at histology. In conclusion, TIO is a debilitating disease characterized by a long diagnostic delay leading to metabolic disturbances and skeletal impairment. Increasing awareness of TIO should decrease its diagnostic delay and the clinical consequences.\n                  <\/jats:p>","DOI":"10.1007\/s00223-022-01005-8","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T08:03:08Z","timestamp":1658304188000},"page":"367-379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases"],"prefix":"10.1007","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7466-1472","authenticated-orcid":false,"given":"Ariadne","family":"Bosman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Palermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Vanderhulst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M. Jan","family":"De Beur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Minisola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Body","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carola","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"key":"1005_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2004.00355.x","volume":"65","author":"SC Schiavi","year":"2004","unstructured":"Schiavi SC, Kumar R (2004) The phosphatonin pathway: new insights in phosphate homeostasis. Kidney Int 65:1\u201314","journal-title":"Kidney Int"},{"key":"1005_CR2","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJM199406093302304","volume":"330","author":"Q Cai","year":"1994","unstructured":"Cai Q, Hodgson SF, Kao PC, Lennon VA, Klee GG, Zinsmiester AR, Kumar R (1994) Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. N Engl J Med 330:1645\u20131649","journal-title":"N Engl J Med"},{"key":"1005_CR3","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 98:6500\u20136505","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1005_CR4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0002-9343(84)90112-8","volume":"77","author":"EA Ryan","year":"1984","unstructured":"Ryan EA, Reiss E (1984) Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases. Am J Med 77:501\u2013512","journal-title":"Am J Med"},{"key":"1005_CR5","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q","volume":"59","author":"N Weidner","year":"1987","unstructured":"Weidner N, Santa Cruz D (1987) Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer 59:1442\u20131454","journal-title":"Cancer"},{"key":"1005_CR6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s00223-020-00691-6","volume":"108","author":"P Florenzano","year":"2021","unstructured":"Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT (2021) Tumor-induced osteomalacia. Calcif Tissue Int 108:128\u2013142","journal-title":"Calcif Tissue Int"},{"key":"1005_CR7","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","volume":"27","author":"Y Jiang","year":"2012","unstructured":"Jiang Y, Xia WB, Xing XP, Silva BC, Li M, Wang O, Zhang HB, Li F, Jing HL, Zhong DR, Jin J, Gao P, Zhou L, Qi F, Yu W, Bilezikian JP, Meng XW (2012) Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature. J Bone Miner Res 27:1967\u20131975","journal-title":"J Bone Miner Res"},{"key":"1005_CR8","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1007\/s00259-018-3971-x","volume":"45","author":"M Paquet","year":"2018","unstructured":"Paquet M, Gauth\u00e9 M, Zhang Yin J, Nataf V, B\u00e9lissant O, Orcel P, Roux C, Talbot JN, Montravers F (2018) Diagnostic performance and impact on patient management of 68Ga-DOTA-TOC PET\/CT for detecting osteomalacia-associated tumours. Eur J Nucl Med Mol Imaging 45:1710\u20131720","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1005_CR9","doi-asserted-by":"crossref","unstructured":"Meyer M, Nicod Lalonde M, Testart N, Jreige M, Kamani C, Boughdad S, Muoio B, Becce F, Schaefer N, Candrian C, Giovanella L, Prior JO, Treglia G, Riegger M (2019) Detection rate of culprit tumors causing osteomalacia using somatostatin receptor PET\/CT: systematic review and meta-analysis. Diagnostics (Basel) 10","DOI":"10.3390\/diagnostics10010002"},{"key":"1005_CR10","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1210\/jc.2016-2052","volume":"101","author":"D El-Maouche","year":"2016","unstructured":"El-Maouche D, Sadowski SM, Papadakis GZ, Guthrie L, Cottle-Delisle C, Merkel R, Millo C, Chen CC, Kebebew E, Collins MT (2016) 68Ga-DOTATATE for tumor localization in tumor-induced osteomalacia. J Clin Endocrinol Metab 101:3575\u20133581","journal-title":"J Clin Endocrinol Metab"},{"key":"1005_CR11","first-page":"463","volume":"62","author":"J Crouzet","year":"1995","unstructured":"Crouzet J, Mimoune H, Beraneck L, Juan LH (1995) Hypophosphatemic osteomalacia with plantar neurilemoma. A review of the literature (100 cases). Rev Rhum Engl Ed 62:463\u2013466","journal-title":"Rev Rhum Engl Ed"},{"key":"1005_CR12","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1002\/1097-0142(19850415)55:8<1691::AID-CNCR2820550814>3.0.CO;2-S","volume":"55","author":"N Weidner","year":"1985","unstructured":"Weidner N, Bar RS, Weiss D, Strottmann MP (1985) Neoplastic pathology of oncogenic osteomalacia\/rickets. Cancer 55:1691\u20131705","journal-title":"Cancer"},{"key":"1005_CR13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1010006811394","volume":"2","author":"MK Drezner","year":"2001","unstructured":"Drezner MK (2001) Tumor-induced osteomalacia. Rev Endocr Metab Disord 2:175\u2013186","journal-title":"Rev Endocr Metab Disord"},{"key":"1005_CR14","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","volume":"18","author":"WH Chong","year":"2011","unstructured":"Chong WH, Molinolo AA, Chen CC, Collins MT (2011) Tumor-induced osteomalacia. Endocr Relat Cancer 18:R53\u2013R77","journal-title":"Endocr Relat Cancer"},{"key":"1005_CR15","doi-asserted-by":"crossref","unstructured":"Rendina D, Abate V, Cacace G, Elia L, De Filippo G, Del Vecchio S, Galletti F, Cuocolo A, Strazzullo P (2022) Tumor induced osteomalacia: a systematic review and individual patient's data analysis. J Clin Endocrinol Metab","DOI":"10.1016\/j.bonr.2022.101503"},{"key":"1005_CR16","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med 18:e1003583","journal-title":"PLoS Med"},{"key":"1005_CR17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF00975318","volume":"5","author":"R Moorjani","year":"1976","unstructured":"Moorjani R, Shaw DG (1976) Feuerstein and Mims syndrome with resistant rickets. Pediatr Radiol 5:120\u2013122","journal-title":"Pediatr Radiol"},{"key":"1005_CR18","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0022-3476(86)80283-9","volume":"109","author":"DE Carey","year":"1986","unstructured":"Carey DE, Drezner MK, Hamdan JA (1986) Hypophosphatemic rickets\/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia. J Pediatr 109:994\u20131000","journal-title":"J Pediatr"},{"key":"1005_CR19","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/bmj.1.4925.1311","volume":"1","author":"PD Saville","year":"1955","unstructured":"Saville PD, Nassim JR, Stevenson FH, Mulligan L, Carey M (1955) Osteomalacia in Von Recklinghausen\u2019s neurofibromatosis; metabolic study of a case. Br Med J 1:1311\u20131313","journal-title":"Br Med J"},{"key":"1005_CR20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00000441-199105000-00006","volume":"301","author":"K Konishi","year":"1991","unstructured":"Konishi K, Nakamura M, Yamakawa H, Suzuki H, Saruta T, Hanaoka H, Davatchi F (1991) Hypophosphatemic osteomalacia in von Recklinghausen neurofibromatosis. Am J Med Sci 301:322\u2013328","journal-title":"Am J Med Sci"},{"key":"1005_CR21","first-page":"411","volume":"45","author":"CE Dent","year":"1976","unstructured":"Dent CE, Gertner JM (1976) Hypophosphataemic osteomalacia in fibrous dysplasia. Q J Med 45:411\u2013420","journal-title":"Q J Med"},{"key":"1005_CR22","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/BF02727183","volume":"66","author":"S Dutta","year":"1999","unstructured":"Dutta S, Bagga A (1999) McCune Albright syndrome and hypophosphatemic rickets. Indian J Pediatr 66:628\u2013631","journal-title":"Indian J Pediatr"},{"key":"1005_CR23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0002-9343(87)90081-7","volume":"82","author":"DS Rao","year":"1987","unstructured":"Rao DS, Parfitt AM, Villanueva AR, Dorman PJ, Kleerekoper M (1987) Hypophosphatemic osteomalacia and adult Fanconi syndrome due to light-chain nephropathy. Another form of oncogenous osteomalacia. Am J Med 82:333\u2013338","journal-title":"Am J Med"},{"key":"1005_CR24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jbspin.2004.10.012","volume":"72","author":"J Narvaez","year":"2005","unstructured":"Narvaez J, Domingo-Domenech E, Narvaez JA, Nolla JM, Valverde J (2005) Acquired hypophosphatemic osteomalacia associated with multiple myeloma. Jt Bone Spine 72:424\u2013426","journal-title":"Jt Bone Spine"},{"key":"1005_CR25","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1259\/bjr\/58168443","volume":"81","author":"SC Chua","year":"2008","unstructured":"Chua SC, O\u2019Connor SR, Wong WL, Ganatra RH (2008) Case report: solitary plasmacytoma of bone with oncogenic osteomalacia: recurrence of tumour confirmed by PET\/CT. A case report with a review of the radiological literature. Br J Radiol 81:e110-114","journal-title":"Br J Radiol"},{"key":"1005_CR26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","volume":"2","author":"RJ Walton","year":"1975","unstructured":"Walton RJ, Bijvoet OL (1975) Nomogram for derivation of renal threshold phosphate concentration. Lancet 2:309\u2013310","journal-title":"Lancet"},{"key":"1005_CR27","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1373\/clinchem.2011.172890","volume":"57","author":"K Wesseling-Perry","year":"2011","unstructured":"Wesseling-Perry K (2011) FGF23: is it ready for prime time? Clin Chem 57:1476\u20131477","journal-title":"Clin Chem"},{"key":"1005_CR28","unstructured":"Fontanarosa P, Christiansen S (2007) Units of measure. In: Press OU (ed) AMA manual of style: a guide for authors and editors. Oxford University Press, New York, pp 787\u2013820"},{"key":"1005_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, Econs MJ, Inwards CY, de Beur SMJ, Mentzel T, Montgomery E, Michal M, Miettinen M, Mills SE, Reith JD, O\u2019Connell JX, Rosenberg AE, Rubin BP, Sweet DE, Vinh TN, Wold LE, Wehrli BM, White FKE, Zaino RJ, Weiss SW (2004) Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity\u2014an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28:1\u201330","journal-title":"Am J Surg Pathol"},{"key":"1005_CR30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/00000478-198907000-00007","volume":"13","author":"MA Nuovo","year":"1989","unstructured":"Nuovo MA, Dorfman HD, Sun CC, Chalew SA (1989) Tumor-induced osteomalacia and rickets. Am J Surg Pathol 13:588\u2013599","journal-title":"Am J Surg Pathol"},{"key":"1005_CR31","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","volume":"294","author":"SM Jan de Beur","year":"2005","unstructured":"Jan de Beur SM (2005) Tumor-induced osteomalacia. JAMA 294:1260\u20131267","journal-title":"JAMA"},{"key":"1005_CR32","doi-asserted-by":"crossref","first-page":"17044","DOI":"10.1038\/nrdp.2017.44","volume":"3","author":"S Minisola","year":"2017","unstructured":"Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT (2017) Tumour-induced osteomalacia. Nat Rev Dis Primers 3:17044","journal-title":"Nat Rev Dis Primers"},{"key":"1005_CR33","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1530\/EC-19-0341","volume":"8","author":"R Shah","year":"2019","unstructured":"Shah R, Lila AR, Ramteke-Jadhav S, Patil V, Mahajan A, Sonawane S, Thadani P, Dcruz A, Pai P, Bal M, Kane S, Shah N, Bandgar T (2019) Tumor induced osteomalacia in head and neck region: single center experience and systematic review. Endocr Connect 8:1330\u20131353","journal-title":"Endocr Connect"},{"key":"1005_CR34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00223-009-9216-z","volume":"84","author":"K Nawrot-Wawrzyniak","year":"2009","unstructured":"Nawrot-Wawrzyniak K, Varga F, Nader A, Roschger P, Sieghart S, Zwettler E, Roetzer KM, Lang S, Weinkamer R, Klaushofer K, Fratzl-Zelman N (2009) Effects of tumor-induced osteomalacia on the bone mineralization process. Calcif Tissue Int 84:313\u2013323","journal-title":"Calcif Tissue Int"},{"key":"1005_CR35","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1359\/jbmr.1997.12.9.1502","volume":"12","author":"E Shane","year":"1997","unstructured":"Shane E, Parisien M, Henderson JE, Dempster DW, Feldman F, Hardy MA, Tohme JF, Karaplis AC, Clemens TL (1997) Tumor-induced osteomalacia: clinical and basic studies. J Bone Miner Res 12:1502\u20131511","journal-title":"J Bone Miner Res"},{"key":"1005_CR36","doi-asserted-by":"crossref","first-page":"e10436","DOI":"10.1002\/jbm4.10436","volume":"5","author":"F Jerkovich","year":"2020","unstructured":"Jerkovich F, Nu\u00f1ez S, Mocarbel Y, Pignatta A, El\u00edas N, Cassinelli H, D\u00edaz AG, Vigovich C, Balonga MC, Cohen AC, Mumbach G, Gonzalez S, Zanchetta JR, Zanchetta MB (2020) Burden of disease in patients with tumor-induced osteomalacia. JBMR plus 5:e10436\u2013e10436","journal-title":"JBMR plus"},{"key":"1005_CR37","doi-asserted-by":"crossref","unstructured":"Colangelo L, Pepe J, Nieddu L, Sonato C, Scillitani A, Diacinti D, Angelozzi M, Cipriani C, Minisola S (2020) Long-term bone mineral density changes after surgical cure of patients with tumor-induced osteomalacia. Osteoporosis Int","DOI":"10.1007\/s00198-020-05369-1"},{"key":"1005_CR38","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/jbmr.4325","volume":"36","author":"MB Zanchetta","year":"2021","unstructured":"Zanchetta MB, Jerkovich F, Nu\u00f1ez S, Mocarbel Y, Pignatta A, El\u00edas N, D\u00edaz AG, Roganovich JM, Vigovich C, Balonga MC, Cohen AC, Mumbach G, Gonzalez S, Plantalech L, Fradinger E, Zanchetta JR (2021) Impaired bone microarchitecture and strength in patients with tumor-induced osteomalacia. J Bone Miner Res 36:1502\u20131509","journal-title":"J Bone Miner Res"},{"key":"1005_CR39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1507\/endocrj.EJ16-0587","volume":"64","author":"J Feng","year":"2017","unstructured":"Feng J, Jiang Y, Wang O, Li M, Xing X, Huo L, Li F, Yu W, Zhong DR, Jin J, Liu Y, Qi F, Lv W, Zhou L, Meng XW, Xia WB (2017) The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases. Endocr J 64:675\u2013683","journal-title":"Endocr J"},{"key":"1005_CR40","doi-asserted-by":"crossref","unstructured":"Dahir K, Zanchetta MB, Stanciu I, Robinson C, Lee JY, Dhaliwal R, Charles J, Civitelli R, Roberts MS, Krolczyk S, Weber T (2021) Diagnosis and management of tumor-induced osteomalacia: perspectives from clinical experience. J Endocr Soc 5:bvab099","DOI":"10.1210\/jendso\/bvab099"},{"key":"1005_CR41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1530\/EC-18-0552","volume":"8","author":"R Pal","year":"2019","unstructured":"Pal R, Bhadada SK, Singhare A, Bhansali A, Kamalanathan S, Chadha M, Chauhan P, Sood A, Dhiman V, Sharma DC, Saikia UN, Chatterjee D, Agashe V (2019) Tumor-induced osteomalacia: experience from three tertiary care centers in India. Endocr Connect 8:266\u2013276","journal-title":"Endocr Connect"},{"key":"1005_CR42","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bone.2008.02.014","volume":"42","author":"I Endo","year":"2008","unstructured":"Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, Inoue D, Minagawa M, Sugimoto T, Yamauchi M, Michigami T, Matsumoto T (2008) Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement. Bone 42:1235\u20131239","journal-title":"Bone"},{"key":"1005_CR43","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1210\/jc.2004-0357","volume":"90","author":"TO Carpenter","year":"2005","unstructured":"Carpenter TO, Ellis BK, Insogna KL, Philbrick WM, Sterpka J, Shimkets R (2005) Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors. J Clin Endocrinol Metab 90:1012\u20131020","journal-title":"J Clin Endocrinol Metab"},{"key":"1005_CR44","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00424-005-1495-2","volume":"451","author":"TJ Berndt","year":"2006","unstructured":"Berndt TJ, Bielesz B, Craig TA, Tebben PJ, Bacic D, Wagner CA, O\u2019Brien S, Schiavi S, Biber J, Murer H, Kumar R (2006) Secreted frizzled-related protein-4 reduces sodium-phosphate co-transporter abundance and activity in proximal tubule cells. Pflugers Archiv-Eur J Physiol 451:579\u2013587","journal-title":"Pflugers Archiv-Eur J Physiol"},{"key":"1005_CR45","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/jc.2005-2105","volume":"91","author":"EA Imel","year":"2006","unstructured":"Imel EA, Peacock M, Pitukcheewanont P, Heller HJ, Ward LM, Shulman D, Kassem M, Rackoff P, Zimering M, Dalkin A, Drobny E, Colussi G, Shaker JL, Hoogendoorn EH, Hui SL, Econs MJ (2006) Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab 91:2055\u20132061","journal-title":"J Clin Endocrinol Metab"},{"key":"1005_CR46","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey P (2003) FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112:683\u2013692","journal-title":"J Clin Invest"},{"key":"1005_CR47","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/sj.ki.5001788","volume":"70","author":"I Bhan","year":"2006","unstructured":"Bhan I, Shah A, Holmes J, Isakova T, Gutierrez O, Burnett SA, Jueppner H, Wolf M (2006) Post-transplant hypophosphatemia: Tertiary \u201chyper-phosphatoninism\u201d? Kidney Int 70:1486\u20131494","journal-title":"Kidney Int"},{"key":"1005_CR48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1258\/acb.2008.008151","volume":"46","author":"BJ Schouten","year":"2009","unstructured":"Schouten BJ, Doogue MP, Soule SG, Hunt PJ (2009) Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia. Ann Clin Biochem 46:167\u2013169","journal-title":"Ann Clin Biochem"},{"key":"1005_CR49","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.bone.2009.06.017","volume":"45","author":"Y Shimizu","year":"2009","unstructured":"Shimizu Y, Tada Y, Yamauchi M, Okamoto T, Suzuki H, Ito N, Fukumoto S, Sugimoto T, Fujita T (2009) Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia. Bone 45:814\u2013816","journal-title":"Bone"},{"key":"1005_CR50","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jbspin.2013.02.014","volume":"80","author":"L Ichchou","year":"2013","unstructured":"Ichchou L, Rist S, Lespessailles E, Prie D, Benhamou CL (2013) Reversible increase in FGF23 in a hypophosphatemic renal and bone disease linked to antiviral therapy by adefovir. Jt Bone Spine 80:668\u2013669","journal-title":"Jt Bone Spine"},{"key":"1005_CR51","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/jcp.2008.055996","volume":"62","author":"R Winters","year":"2009","unstructured":"Winters R, Bihlmeyer S, McCahill L, Cooper K (2009) Phosphaturic mesenchymal tumour-mixed connective tissue variant without oncogenic osteomalacia. J Clin Pathol 62:760\u2013761","journal-title":"J Clin Pathol"},{"key":"1005_CR52","doi-asserted-by":"crossref","unstructured":"Latifyan SB, Vanhaeverbeek M, Klastersky J (2014) Tumour-associated osteomalacia and hypoglycaemia in a patient with prostate cancer: is Klotho involved? BMJ Case Reports 2014","DOI":"10.1136\/bcr-2014-206590"},{"key":"1005_CR53","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1210\/jc.2012-3473","volume":"98","author":"DE Leaf","year":"2013","unstructured":"Leaf DE, Pereira RC, Bazari H, J\u00fcppner H (2013) Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma. J Clin Endocrinol Metab 98:887\u2013891","journal-title":"J Clin Endocrinol Metab"},{"key":"1005_CR54","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/jbmr.1881","volume":"28","author":"WH Chong","year":"2013","unstructured":"Chong WH, Andreopoulou P, Chen CC, Reynolds J, Guthrie L, Kelly M, Gafni RI, Bhattacharyya N, Boyce AM, El-Maouche D, Crespo DO, Sherry R, Chang R, Wodajo FM, Kletter GB, Dwyer A, Collins MT (2013) Tumor localization and biochemical response to cure in tumor-induced osteomalacia. J Bone Miner Res 28:1386\u20131398","journal-title":"J Bone Miner Res"},{"key":"1005_CR55","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jbmr.3903","volume":"35","author":"X Li","year":"2020","unstructured":"Li X, Jiang Y, Huo L, Wu H, Liu Y, Jin J, Yu W, Lv W, Zhou L, Xia Y, Wang O, Li M, Xing X, Chi Y, Jiajue R, Cui L, Meng X, Xia W (2020) Nonremission and recurrent tumor-induced osteomalacia: a retrospective study. J Bone Miner Res 35:469\u2013477","journal-title":"J Bone Miner Res"},{"key":"1005_CR56","first-page":"119","volume":"58","author":"LE Aguirre","year":"2010","unstructured":"Aguirre LE, Colleran K, Kapsner P (2010) Tumor induced osteomalacia with no clinically apparent tumor. J Investig Med 58:119","journal-title":"J Investig Med"},{"key":"1005_CR57","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2796.2010.02262.x","volume":"268","author":"N Ito","year":"2010","unstructured":"Ito N, Shimizu Y, Suzuki H, Saito T, Okamoto T, Hori M, Akahane M, Fukumoto S, Fujita T (2010) Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia: letter to the editor. J Intern Med 268:390\u2013394","journal-title":"J Intern Med"},{"key":"1005_CR58","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2169\/internalmedicine.47.0665","volume":"47","author":"C Hoshino","year":"2008","unstructured":"Hoshino C, Satoh N, Sugawara S, Kuriyama C, Kikuchi A, Ohta M (2008) Sporadic adult-onset hypophosphatemic osteomalacia caused by excessive action of fibroblast growth factor 23. Intern Med 47:453\u2013457","journal-title":"Intern Med"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-022-01005-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-022-01005-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-022-01005-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T14:54:16Z","timestamp":1700837656000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-022-01005-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":58,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["1005"],"URL":"https:\/\/doi.org\/10.1007\/s00223-022-01005-8","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,20]]},"assertion":[{"value":"5 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AB is supported by a Grant from Health\u2009~\u2009Holland (PhosphoNorm; LSHM18029). AP, JV WX, and JB declare they have no financial interests. SB received grants from Ultragenyx and consulting fees from Ultragenyx, Amgen and Inozyme. SB serves on the Data Safety Monitory Board of NIDCR (NIH) and NIDDK (FIT4KIDS); on the advisory board of Ultragenyx, Amgen and Inozyme; and in the scientific advisory board of the XLH network. SF received lecture fees from Kyowa Kirin, and is president of the Japanese Society for Bone and Mineral Research (JSBMR). SM served as speaker for Abiogen, Bruno Farmaceutici, Diasorin, Kyowa Kirin, UCB. He also served in advisory boards of Eli Lilly, Kyowa Kirin, UCB. MCZ reports that her institution has received a research grant from Kyowa Kirin and she is an unpaid board member of the steering committee of the Kyowa Kirin International XLH registry.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}